European Journal of Nuclear Medicine and Molecular Imaging

Journal Metrics
(Based on the publications from the last 4 years)
(from 2020-04-01 to roughly 2024-04-01)
Number of papers1907
H4-Index58
TQCC14
Average citations11.114
Median citations5
Impact Factor9.100 (based on Web of Science 2022)

(API-Link)

Categories & Ranks
Metric:
(Based on the publications from the last 4 years)
Most cited by this journal
(Based on citations to the other journals in the most recent 30 papers in this journal, at least if metadata about citations were available; last updated 2022-12-13)
Impactful Papers
(Based on publications since 2023; last updated 2023-12-19)
Altmetric Attention Score: 414
Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods
European Journal of Nuclear Medicine and Molecular Imaging 2023-06-10
Altmetric Attention Score: 400
[177Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models
European Journal of Nuclear Medicine and Molecular Imaging 2023-12-11
Altmetric Attention Score: 353
[18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label,
European Journal of Nuclear Medicine and Molecular Imaging 2023-06-26
Altmetric Attention Score: 77
A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine
European Journal of Nuclear Medicine and Molecular Imaging 2023-09-22
Altmetric Attention Score: 35
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
European Journal of Nuclear Medicine and Molecular Imaging 2023-06-01
Ad
0.012816905975342